Drug
Travoprost clinical trials
Also written Travatan, iDose TR and PRO 179.
- studies test it
- 80
- open now
- 2
- in phase 3
- 21
- first study started
- 2000
Keep track of what changes. Save the Travoprost studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Other names
Studies by the year they started
80 studies that test it; most in 2008 (14)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 4 |
| 2004 | 3 |
| 2006 | 4 |
| 2007 | 10 |
| 2008 | 14 |
| 2009 | 3 |
| 2010 | 4 |
| 2011 | 12 |
| 2012 | 4 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2023 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 8
- Phase 3
- 21
- Phase 4
- 44
- No phase
- 6
What it is tested for
Each study’s main condition, where its own words name it.
- Glaucoma
- 25
Who runs them
Industry 62 · Other 18
Alcon Research (46) · Glaukos Corporation (7) · Allergan (4) · Ocular Therapeutix, Inc. (2) · The University of Hong Kong (1) · Pfizer's Upjohn has merged with Mylan to form Viatris Inc. (1) · Université de Sherbrooke (1) · Laboratorios Sophia S.A de C.V. (1)
Often tested with
Tested in the same studies.
Latanoprost (14) · Bimatoprost (9) · Timolol (7) · Brinzolamide (4) · Hypromellose Derivatives (3) · Brimonidine (2) · Dorzolamide (2) · Bimatoprost Ophthalmic Solution (2)
Studies
Open first, then newest update. How each study uses Travoprost is read from its arms, and is right about nine times in ten.
Testing it · 80
- Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery AloneRecruitingPhase 4Glaukos CorporationNCT06848946Written as iDose TR (travoprost intracameral implant) 75 µg in conjunction with cataract surgery
- Standalone iStent Infinite and iDose TR for Management of Moderate to Severe Open Angle GlaucomaRecruitingPhase 4Jonathon MyersNCT07228221Written as iDose TR (Travoprost intracameral Implant) 75mcg
- Stop Retinal Ganglion Cell Dysfunction StudyTerminatedPhase 3University of MiamiNCT02390284Written as Travoprost
- Performance of the Travoprost Intraocular ImplantCompletedPhase 2Glaukos CorporationNCT06582732Written as Travoprost Intracameral Implant exchanged at Month 12
- Travoprost Intraocular Implant in Conjunction With Cataract SurgeryActive, not recruitingPhase 3Glaukos CorporationNCT06061718Written as iDose TR
- Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG)CompletedPhase 4Alcon ResearchNCT00762645Written as Travoprost 0.004% (Travatan)
- Azopt (Brinzolamide 1.0%) Plus Travatan (Travoprost 0.004%) in Treating Patients With Chronic Angle-Closure Glaucoma (CACG)TerminatedPhase 4Alcon ResearchNCT00758342Written as Travoprost 0.004% + Brinzolamide 1.0%
- Study of Exchange of Travoprost Intraocular ImplantCompletedPhase 2Glaukos CorporationNCT04615403Written as Travoprost
- Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or TravoprostCompletedPhase 4Glaukos CorporationNCT01444040Written as Travoprost
- Two Trabecular Micro-bypass Stents & Postoperative Travoprost to Treat Glaucoma Subjects on Two Hypotensive AgentsCompletedPhase 4Glaukos CorporationNCT02873806Written as Topical travoprost
- Phase 3 Study Evaluating Safety and Efficacy of OTX-TP in Subjects With OAG or OHTCompletedPhase 3Ocular Therapeutix, Inc.NCT02914509Written as Travoprost
- Interval Intraocular Pressure in Intravitreal Injection StudyCompletedNot applicableThe University of Hong KongNCT04868175Written as Travatan
- Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the USCompletedPhase 4Pfizer's Upjohn has merged with Mylan to form Viatris Inc.NCT00847483Written as Travoprost 004% sterile ophthalmic solution
- Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular HypertensionCompletedPhase 4Université de SherbrookeNCT02796560Written as Brand name travoprost
- Effect Of Topical Prostaglandin F2α Analogs,Fractional CO2 Laser, Excimer Laser Or Their Combination In Treatment Of VitiligoStatus unknownPhase 4Assiut UniversityNCT04577027Written as Topical travoprost 0.004% solution
- Safety and Tolerability of the Ophthalmic Solution PRO-179 Compared With Travatan®CompletedPhase 1Laboratorios Sophia S.A de C.V.NCT03965052Written as PRO 179
- Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle GlaucomaCompletedPhase 4Afyon Kocatepe University HospitalNCT03966560Written as Travoprost and Timolol
- How Similar Are Changes to the Surface of the Eye When Two Different Glaucoma Eye Drops Are Used?CompletedPhase 4Wills EyeNCT00798694Written as Travatan Z
- Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent)or TravoprostCompletedPhase 4Glaukos CorporationNCT01443988Written as Travoprost
- Divided Dose of TRAVATAN®CompletedPhase 2Alcon ResearchNCT01298687Written as Travoprost Ophthalmic Solution, 0.004%
See all 80 studies that test Travoprost →
Given in every arm · 5 — Travoprost is usual care beside what is tested
- Travoprost Intraocular Implant + iStent InfiniteRecruitingPhase 4Glaukos CorporationNCT06066645Written as Travoprost Intraocular Implant
- Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®TerminatedPhase 4Alcon ResearchNCT02730871Written as Travoprost 0.004%/timolol 0.5% solution
- Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension GlaucomaCompletedPhase 4Novartis PharmaceuticalsNCT03150160Written as travoprost 0.004% ophthalmic solution
- Efficacy of Travoprost/Timolol for Uncontrolled Intraocular PressureCompletedPhase 4Alcon ResearchNCT02003391Written as Travoprost 0.004% / timolol 0.5% fixed combination ophthalmic solution
- Effect of SIMBRINZA® Suspension as an Added Therapy to TRAVATAN Z®CompletedPhase 4Alcon ResearchNCT01937299Written as Travoprost 0.004% ophthalmic solution
As the comparator · 14 — what is tested is compared with Travoprost
- Travoprost Ophthalmic Topical Cream for Open-angle Glaucoma or Ocular HypertensionRecruitingPhase 2Glaukos CorporationNCT06152861Written as Travoprost Ophthalmic Solution, 0.004%
- Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%CompletedPhase 4AllerganNCT00440011Written as travoprost 0.004% eye drops
- Evaluation of Hyperemia With the Use of Ocular Prostaglandin AnaloguesCompletedPhase 4AllerganNCT00539526Written as travoprost 0.004%
- A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionCompletedPhase 3Alcon ResearchNCT00293761Written as Travoprost (TRAVATAN)
- Effect of Selective Laser Trabeculoplasty Versus Travoprost on Circardian Intraocular PressureCompletedPhase 4Prince of Songkla UniversityNCT02105311Written as Travoprost
- Safety and Efficacy Study of Catioprost® (Unpreserved Latanoprost 0.005% Emulsion) Compared to Travatan Z® to Treat Glaucoma and Ocular Surface DiseaseCompletedPhase 2Santen SASNCT01254370Written as Travatan Z
- 6-Week Proof-of-Concept Study of Travoprost/Brinzolamide Ophthalmic Suspension in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedPhase 2Alcon ResearchNCT02140060Written as Travoprost 0.004% ophthalmic solution TRAVATAN Z®
- A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 DaysCompletedPhase 2Aerie PharmaceuticalsNCT01789736Written as Travoprost Ophthalmic Solution 0.004%
- Safety and Intraocular Pressure (IOP) Lowering Effect of AL-59412CTerminatedPhase 2Alcon ResearchNCT01312454Written as Travoprost injectable solution
- Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose TravoprostCompletedPhase 2Alcon ResearchNCT00637130Written as TRAVATAN
- Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPTTerminatedPhase 3Alcon ResearchNCT00767494Written as Travatan
- Three Month Safety and Efficacy Study of TRAVATAN® Versus Travoprost Ophthalmic Solution, 0.004%WithdrawnPhase 3Alcon ResearchNCT01452009Written as TRAVATAN®
- Argon Laser Peripheral Iridoplasty for Primary Angle Closure GlaucomaStatus unknownPhase 3Singapore National Eye CentreNCT00980473Written as Travatan/ Timolol/Azopt
- Intraocular Pressure (IOP) Lowering Effect of Selective Laser Trabeculoplasty Versus Prostaglandin Analogues in Angle Closure GlaucomaStatus unknownPhase 3Singapore Eye Research InstituteNCT01004900Written as Travoprost/ Timolol/ Azopt/ Brimonidine
Codes
What other systems call Travoprost · ClinicalTrials.gg INT006610
- MeSH (NLM) D000069557TravoprostConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) WJ68R08KX9TRAVOPROSTConfirmed FDA, NLM, Wikidata
- RxNorm 283809Confirmed FDA, Wikidata
- Wikidata Q2193376travoprostConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C47766TravoprostOne source FDA
- DrugBank DB00287One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069557 | Travoprost | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | WJ68R08KX9 | TRAVOPROST | Confirmed FDA, NLM, Wikidata |
| RxNorm | 283809 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2193376 | travoprost | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C47766 | Travoprost | One source FDA |
| DrugBank | DB00287 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.